New hope for duchenne: Long-Term drug trial aims to slow muscle decline
NCT ID NCT04433234
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 25 times
Summary
This study tests the long-term safety and effectiveness of an experimental drug called DS-5141b in people with Duchenne muscular dystrophy (DMD). It includes 8 participants who have already completed an earlier study of the same drug. Researchers will monitor side effects and measure changes in muscle function, such as walking distance and strength, over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kobe University Hospital
Hyōgo, 650-0017, Japan
-
National Center of Neurology and Psychiatry
Tokyo, Kodaira-Shi, 187-8551, Japan
Conditions
Explore the condition pages connected to this study.